MedTrace Logo

Topical Garlic Concentrate for Alopecia Areata in Children

NCT02691117 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2018-04-19

No results posted yet for this study

Summary

Management of pediatric alopecia is particularly challenging given the chronicity of the condition, limited therapeutic response and devastating psychological effects. There is a paucity of safe and effective therapies in this population.

The investigators propose to conduct and open label, prospective cohort pilot study using topical garlic concentrate ( GarlicRich) for treatment of children with alopecia areata. Study medication will be applied topically on affected area of the skin daily for 6 months. Follow up visits will occur monthly to access the efficacy and safety of the proposed treatment .

Conditions

Interventions

DRUG

garlic concentrate

Topical application of GarlicRich gel on the scalp areas affected with alopecia areata once a day for 6 months

Sponsors & Collaborators

  • Dermatology Foundation

    collaborator OTHER

  • Elena Pope

    lead OTHER

Principal Investigators

  • Elena Pope, MD, MSc · The Hospital for Sick Children

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-10
Primary Completion
2017-08-15
Completion
2017-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02691117 on ClinicalTrials.gov